# reload+after+2024-01-21 21:45:26.164560
address1§1200 Avenue of the Americas
address2§Suite 200
city§New York
state§NY
zip§10036
country§United States
phone§332 255 9818
website§https://www.imux.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 3 clinical for treatment of multiple sclerosis, including relapsing multiple sclerosis and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
fullTimeEmployees§80
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Duane D. Nash J.D., M.B.A., M.D.', 'age': 52, 'title': 'Executive Chairman', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 433403, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Daniel  Vitt Ph.D.', 'age': 55, 'title': 'CEO, President & Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 728403, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Glenn  Whaley CPA', 'age': 55, 'title': 'Chief Financial Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 522210, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Andreas  Muehler M.D., Ph.D.', 'age': 59, 'title': 'Chief Medical Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 599573, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Hella  Kohlhof', 'age': 50, 'title': 'Chief Scientific Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Jessica  Breu', 'title': 'Head of Investor Relations & Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Inderpal  Singh', 'age': 57, 'title': 'General Counsel', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Patrick  Walsh', 'age': 40, 'title': 'Chief Business Officer', 'yearBorn': 1983, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§9
compensationRisk§6
shareHolderRightsRisk§6
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.931
currency§USD
dateShortInterest§1702598400
forwardEps§-1.85
pegRatio§-0.04
exchange§NMS
quoteType§EQUITY
shortName§Immunic, Inc.
longName§Immunic, Inc.
firstTradeDateEpochUtc§1397741400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§9418eda4-bdb2-33d3-9268-92e0d8463b7a
gmtOffSetMilliseconds§-18000000
targetHighPrice§28.0
targetLowPrice§7.0
targetMeanPrice§16.67
targetMedianPrice§15.0
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§3.458
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
